• C-Reactive Protein (CRP)
  • PML-RARA Translocation, t(15;17) by RT-PCR, Quantitative
  • Trypanosoma cruzi (T. cruzi) Antibody, IgG and IgM
  • Uric Acid, Body Fluid
  • MLH1 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Carnitine Palmitoyltransferase 1A (CPT1A) Mutation Analysis
  • Miller-Dieker Syndrome, 17p13.3 Deletion, FISH
  • JC Polyomavirus, Molecular
  • Aspergillus Precipitins Antibody, IgG
  • Factor II (Prothrombin) Mutation
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

Additional Testing
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.